Pharmaceutical Glass Packaging Market Summary

The global pharmaceutical glass packaging market size was estimated at USD 19.75 billion in 2023 and is projected to reach USD 37.62 billion by 2030, growing at a CAGR of 9.8% from 2024 to 2030. This strong growth trajectory reflects the rising demand for safe, reliable, and high-quality packaging solutions required for pharmaceutical products worldwide.

Extensive utilization of generic injectable drugs, coupled with high demand from the pharmaceutical industry, is anticipated to drive market growth. The increasing production of vaccines, biologics, and injectable medications requires packaging materials that offer superior protection, chemical stability, and compatibility with sensitive drug formulations.

Limestone (CaCO3), soda ash (Na2CO3), cullet, and sand (SiO2) comprise the overall chemical composition of glass. These raw materials form the base structure of pharmaceutical-grade glass and contribute to its transparency, strength, and thermal resistance.

For pharmaceutical packaging applications, the most common cations found in glassware are barium, zinc, ferrous, magnesium, calcium, potassium, sodium, boron, aluminum, and silicon. These elements influence the properties of glass such as chemical resistance, hardness, and durability, making glass suitable for storing a wide range of pharmaceutical products without interaction or contamination.

Key Market Trends & Insights

• North America dominated the market and accounted for more than 35.5% share of global revenue in 2023. Strong pharmaceutical manufacturing presence, advanced healthcare infrastructure, and strict regulatory standards support regional dominance.
• By product, pharmaceutical glass bottles were the largest market segment, accounting for more than 34.2% in 2023. Their widespread use in storing liquid medications and injectables drives segment leadership.
• By drug type, the generic drug type led the market and accounted for more than 72.9% share of the global revenue in 2023. High consumption of cost-effective generic medicines continues to fuel demand for pharmaceutical glass packaging.

Order a free sample PDF of the Pharmaceutical Glass Packaging Market Intelligence Study, published by Grand View Research.

Market Size & Forecast

• 2023 Market Size: USD 19.75 Billion
• 2030 Projected Market Size: USD 37.62 Billion
• CAGR (2024-2030): 9.88%
• North America: Largest market in 2023

Key Companies & Market Share Insights

Numerous pharmaceutical glass manufacturing companies are primarily concentrated in the developed regions such as Europe and North America resulting in well-established supply chain and production system in the regions. However, manufacturers are shifting their base to countries such as Brazil, India, and China due to low labor costs and growth of opportunities offered by these countries. The generic sector is expected to drive the demand for pharmaceutical glass packaging in these countries over the forecast period.

• In June 2023, Müller + Müller, the manufacturer of primary packaging materials made of tubular glass for the pharmaceutical industry, has invested 15 million EUR at its vial manufacturing site in Holzminden. The investment includes up to 14 new production lines as well as a corresponding clean room.
• In June 2023, Corning and SGD Pharma with joint venture open a new glass tubing facility and expand access to Corning Velocity Vial technology in in Telangana, India. Manufacturing of Velocity Vials at SGD Pharma’s facility in Vemula, India, is expected to begin in 2024. Pharmaceutical tubing production is expected to begin in 2025.

Key Players

• Corning Incorporated
• Nipro Corporation
• SGD S.A.
• Stoelzle Oberglas GmbH
• Bormioli Pharma S.p.A.
• West Pharmaceutical Services, Inc.
• Schott AG
• Gerresheimer AG
• Shandong Medicinal Glass Co., Ltd.
• Beatson Clark
• Ardagh Group S.A
• Arab Pharmaceutical Glass Co.
• Piramal Enterprises Ltd.
• Şişecam Group
• Owens-Illinois, Inc.
• DWK Life sciences

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion

The pharmaceutical glass packaging market is set for robust growth driven by rising demand for injectable and generic drugs and the need for high-quality, chemically stable packaging solutions. The inherent properties of glass make it ideal for protecting sensitive pharmaceutical formulations. North America’s leadership highlights strong manufacturing capabilities and regulatory compliance. Dominance of glass bottles and generic drug applications reflects widespread industry adoption. Overall, continuous pharmaceutical innovation and increasing healthcare demand will sustain long-term growth in the global pharmaceutical glass packaging market.